Real-time enrollment status for this neuroendocrine tumors clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:16 AM UTC
| NCT Number | NCT05636618 |
| Recruiting Status | Recruiting |
| Condition | Neuroendocrine Tumors |
| Phase | Clinical Trial |
| Target Enrollment | 260 participants |
| Active Locations | 15 sites in the US |
| Sponsor | Perspective Therapeutics |
| Last Updated on CT.gov | November 24, 2025 (Nov 24, 2025) |
As of March 2, 2026: Clinical trial NCT05636618 is currently recruiting participants. This clinical trial study for neuroendocrine tumors is actively seeking new participants at 15 locations across the United States. The study is sponsored by Perspective Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05636618 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 15 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05636618 was last updated Nov 24, 2025 (November 24, 2025). HelloStudys verifies this status automatically.